-
Single‐cell profiling highlight pathogenic myeloid features in house dust mite‐induced murine model of airway inflammation Allergy (IF 12.4) Pub Date : 2024-05-13 Jiachen Liu, Jiaoyan Lv, Sijie Chen, Jie Ma, Jiaying Yao, Zan Yuan, Chunyuan Yang, Xiao Li, Xuegong Zhang, Yunping Zhu, Jianhong Zhang, Li Wu
-
Anaphylaxis in outpatients: A 5‐year retrospective study on incidence and clinical characteristics at a university hospital in Wuhan, China Allergy (IF 12.4) Pub Date : 2024-05-11 Le Li, Hao Chen, Nan Huang, Wenjing Li, Yaqi Yang, Dongxia Ma, Pascal Demoly, Rongfei Zhu
-
Proteomics and metabolomics of sputum reveal the potential impact of allergic rhinitis on asthma Allergy (IF 12.4) Pub Date : 2024-05-11 Yujuan Yang, Limei Cui, Pengyi Yu, Jing Guo, Jianwei Wang, Hanrui Wang, Zheying Song, Zhaoxue Zhai, Tong Li, Guangkuo Wang, Yu Yuemei Sun, Yu Zhang, Xicheng Song
-
Meteorin‐like protein/METRNL/Interleukin‐41 ameliorates atopic dermatitis‐like inflammation Allergy (IF 12.4) Pub Date : 2024-05-10 Danqi Huang, Xiuting Liu, Xun Gao, Chun Kit Choi, Giovanni Giglio, Luay Farah, Ting‐Fan Leung, Katie Ching‐Yau Wong, Lea Ling‐Yu Kan, Jeffrey Wing‐Heung Chong, Qing‐Jun Meng, Jinyue Liao, Phyllis Fung‐Yi Cheung, Chun‐Kwok Wong
BackgroundMeteorin‐like protein (METRNL)/Interleukin‐41 (IL‐41) is a novel immune‐secreted cytokine/myokine involved in several inflammatory diseases. However, how METRNL exerts its regulatory properties on skin inflammation remains elusive. This study aims to elucidate the functionality and regulatory mechanism of METRNL in atopic dermatitis (AD).MethodsMETRNL levels were determined in skin and serum
-
Comparison of upper and lower airway expression of SARS‐COV‐2 receptors in allergic asthma Allergy (IF 12.4) Pub Date : 2024-05-10 Maral Ranjbar, Christiane E. Whetstone, Ruth P. Cusack, Dhuha Al‐Sajee, Hafsa Omer, Nadia Alsaji, Terence Ho, MyLinh Duong, Patrick Mitchell, Imran Satia, Paul K. Keith, Yanqing Xie, Jonathan MacLean, Doron D. Sommer, Paul M. O'Byrne, Roma Sehmi, Gail M. Gauvreau
-
Longitudinal peanut and Ara h 2 specific‐IgE, ‐IgG4, and ‐IgG4/‐IgE ratios are associated with the natural resolution of peanut allergy in childhood Allergy (IF 12.4) Pub Date : 2024-05-09 Kayla M. Parker, Thanh D. Dang, Rushani Wijesuriya, Victoria X. Soriano, Adrian J. Lowe, Shyamali C. Dharmage, Paxton Loke, Mimi L. K. Tang, Katie J. Allen, Jennifer J. Koplin, Kirsten P. Perrett, Rachel L. Peters
BackgroundThere are no studies of longitudinal immunoglobulin measurements in a population‐based cohort alongside challenge‐confirmed peanut allergy outcomes. Little is known about biomarkers for identifying naturally resolving peanut allergy during childhood.ObjectivesTo measure longitudinal trends in whole peanut and component Ara h 2 sIgE and sIgG4 in the first 10 years of life, in a population
-
Importance of SREBP signaling in controlling lipid metabolism and homeostasis in B cells for future vaccine design Allergy (IF 12.4) Pub Date : 2024-05-08 Zsófia Unger, Alina Kuklinski, Cristina Gomez‐Casado
-
How to hit the allergy target: A critical appraisal of intralymphatic immunotherapy with practical recommendations on ultrasound‐guided injections Allergy (IF 12.4) Pub Date : 2024-05-07 Stephan Flory, Bjarke Hviid‐Vyff, Lara Šošić, Johannes M. Schmid, Lars Ahlbeck, Emma C. J. Widmer, Claudia C. V. Lang, Kristian Ikenberg, Thomas M. Kündig, Hans Jürgen Hoffmann, Pål Johansen
BackgroundIntralymphatic immunotherapy (ILIT) represents a promising novel approach treating allergic diseases. However, no standardized procedures or recommendations have been established or reported, despite the recognized fact that treatment efficacy relies on the ability to inject the allergen intranodally.ObjectiveWe aim to provide a critical appraisal of ILIT as a method of allergen immunotherapy
-
Correspondence to “The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark” Allergy (IF 12.4) Pub Date : 2024-05-06 Celeste Porsbjerg, Benedikt Fritzsching, Nick Freemantle, Marco Contoli, Andreas Kallsoy Slættanes, Christian Woehlk
-
Mouse IgE clone SPE‐7 can contain functional mouse IgG Allergy (IF 12.4) Pub Date : 2024-05-06 Michalina Sypka, Marianne Zwicker, Sophie Braga Lagache, Anne‐Christine Uldry, Monique Vogel, Paul Engeroff
-
Four years into the COVID‐19 pandemic: Timely published articles for patient care and EAACI's leadership role Allergy (IF 12.4) Pub Date : 2024-05-04 María José Torres, Ludger Klimek, Ioana Agache, Marek Jutel, Mübeccel Akdis, Mohamed H. Shamji, Cezmi A. Akdis
-
Digitally‐enabled, person‐centred care (PCC) in allergen immunotherapy: An ARIA‐EAACI Position Paper Allergy (IF 12.4) Pub Date : 2024-05-03 Oliver Pfaar, Bernardo Sousa‐Pinto, Nikolaos G. Papadopoulos, Désirée E. Larenas‐Linnemann, Michal Ordak, Maria J. Torres, Ralph Mösges, Ludger Klimek, Torsten Zuberbier, Paolo M. Matricardi, Uwe E. Berger, Markus Berger, Stephanie Dramburg, Vera Mahler, Sanna K. Toppila‐Salmi, Karl‐Christian Bergmann, Markus Ollert, Salvatore Tripodi, Marek Jutel, Ioana Agache, Ibon Eguiluz‐Gracia, G. Walter Canonica
In rhinitis and asthma, several mHealth apps have been developed but only a few have been validated. However, these apps have a high potential for improving person‐centred care (PCC), especially in allergen immunotherapy (AIT). They can provide support in AIT initiation by selecting the appropriate patient and allergen shared decision‐making. They can also help in (i) the evaluation of (early) efficacy
-
Efficacy and safety of a 7‐week immunotherapy protocol with aluminium hydroxide adsorbed hymenoptera venom Allergy (IF 12.4) Pub Date : 2024-05-03 Bogusia Kasternow, Da‐In S. Kim, Patrick F. K. Yong
-
-
The effects of inhaled corticosteroids on healthy airways Allergy (IF 12.4) Pub Date : 2024-04-30 Emanuele Marchi, Timothy S. C. Hinks, Matthew Richardson, Latifa Khalfaoui, Fiona A. Symon, Poojitha Rajasekar, Rachel Clifford, Beverley Hargadon, Cary D. Austin, Julia L. MacIsaac, Michael S. Kobor, Salman Siddiqui, Jordan S. Mar, Joseph R. Arron, David F. Choy, Peter Bradding
BackgroundThe effects of inhaled corticosteroids (ICS) on healthy airways are poorly defined.ObjectivesTo delineate the effects of ICS on gene expression in healthy airways, without confounding caused by changes in disease‐related genes and disease‐related alterations in ICS responsiveness.MethodsRandomized open‐label bronchoscopy study of high‐dose ICS therapy in 30 healthy adult volunteers randomized
-
Medical algorithm: Diagnosis and management of adult food protein‐induced enterocolitis syndrome Allergy (IF 12.4) Pub Date : 2024-04-30 Purificación Gonzalez‐Delgado, Sara Anvari, Ana Entrala, Sonsoles Infante
-
Neutrophil‐driven and interleukin‐36γ‐associated ocular surface inflammation in chronic Stevens–Johnson syndrome Allergy (IF 12.4) Pub Date : 2024-04-29 Madhuri Amulya Koduri, Tejaswini Pingali, Deeksha Prasad, Vijay Singh, Swati Singh, Swapna S. Shanbhag, Sayan Basu, Vivek Singh
PurposeThis study aims to elucidate the tear proteome and understand the underlying molecular mechanisms involved in the ocular complications following Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN).MethodsMass spectrometry (MS) was performed to quantify the tear fluid proteins from chronic SJS/TEN patients (n = 22 eyes) and age‐ and gender‐matched controls (n = 22 eyes). The candidate
-
LPS in combination with amoxicillin increases BAT sensitivity to amoxicillin IgE‐mediated hypersensitivity Allergy (IF 12.4) Pub Date : 2024-04-27 Jose A. Céspedes, Rubén Fernández‐Santamaría, Gador Bogas, Adriana Ariza Veguillas, Inmaculada Doña, María Salas, Marina Labella, Tahia D. Fernández Duarte, Cristobalina Mayorga, María J. Torres, Cecilia A. Frecha
-
Association between Apgar scores within normal range and development of asthma, allergic rhinitis and eczema in childhood: A Danish nationwide register study Allergy (IF 12.4) Pub Date : 2024-04-27 Erik Sören Halvard Hansen, Hannah Kaiser, Kristine Tronier Hansen, Klaus Bønnelykke, Bo Chawes, Vibeke Backer, Christian Torp‐Pedersen, Charlotte Suppli Ulrik, Nicklas Brustad
-
The use of omalizumab in food allergy Allergy (IF 12.4) Pub Date : 2024-04-27 Shifaa Alkotob, Philippe Bégin, Aikaterini Anagnostou
-
Clovibactin: Discovery and antimicrobial mechanism of action Allergy (IF 12.4) Pub Date : 2024-04-26 Ana M. Pérez‐Moreno, Pablo Torres, Juan L. Paris
-
Continuous improvement of FEV1 in severe eosinophilic asthmatics on anti‐interleukin‐5 therapy Allergy (IF 12.4) Pub Date : 2024-04-25 Alain Michils, Jean‐Pierre Makhoul, Nathan Blekic, Amaryllis Haccuria, Silvia Perez‐Bogerd, Andreï Malinovschi, Alain Van Muylem
-
Clinical applicability of AI‐based prognosis prediction for a rare ocular surface disease Allergy (IF 12.4) Pub Date : 2024-04-25 Mayumi Ueta, Yasuhito Watanabe, Charles Melby‐Thompson, Chie Sotozono, Shigeru Kinoshita
-
Ambient pollen exposure and pollen allergy symptom severity in the EPOCHAL study Allergy (IF 12.4) Pub Date : 2024-04-25 Axel Luyten, Alexandra Bürgler, Sarah Glick, Marek Kwiatkowski, Regula Gehrig, Minaya Beigi, Karin Hartmann, Marloes Eeftens
BackgroundAmbient pollen exposure causes nasal, ocular, and pulmonary symptoms in allergic individuals, but the shape of the exposure–response association is not well characterized. We evaluated this association and determined (1) whether symptom severity differs between subpopulations; (2) how the association changes over the course of the pollen season; and (3) which pollen exposure time lags affect
-
Response of sputum periostin to anti‐T2 biologics treatment in severe asthma Allergy (IF 12.4) Pub Date : 2024-04-23 Parameswaran Nair, Katherine Radford, Satoshi Nunomura, Manali Mukherjee, Kenji Izuhara
-
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry Allergy (IF 12.4) Pub Date : 2024-04-23 Marek Niedoszytko, Aleksandra Gorska, Knut Brockow, Patrizia Bonadonna, Magdalena Lange, Hanneke Kluin‐Nelemans, Hanneke Oude‐Elberink, Vito Sabato, Khalid Shoumariyeh, Dagmar von Bubnoff, Sabine Müller, Anja Illerhaus, Michael Doubek, Irena Angelova‐Fischer, Olivier Hermine, Michel Arock, Chiara Elena, Luca Malcovati, Akif Selim Yavuz, Tanja Daniela Schug, Anna Belloni Fortina, Várkonyi Judit, Jason
BackgroundHypersensitivity reactions (HR) are common in mastocytosis. However, little is known about triggers and risk factors. The registry of the European Competence Network on Mastocytosis (ECNM) enables reliable studies in a larger cohort of mastocytosis patients. We assessed prevalence, triggers and risk factors of HR in adults with mastocytosis in the ECNM registry.MethodsData were collected
-
Oral immunotherapy in alpha‐gal red meat allergy: Could specific IgE be a potential biomarker in monitoring management? Allergy (IF 12.4) Pub Date : 2024-04-20 D. Ünal, D. Eyice‐Karabacak, A. Kutlu, S. Demir, O. C. Tüzer, F. A. Arslan, S. R. Işık, A. Gelincik
-
Inhibition of RNase 7 by RNase inhibitor promotes inflammation and Staphylococcus aureus growth: Implications for atopic dermatitis Allergy (IF 12.4) Pub Date : 2024-04-20 Franziska Rademacher, Annika Scheel, Regine Gläser, Lena Schröder, Nina Heinemann, Joachim Bartels, Sascha Gerdes, Dora Stölzl, Elke Rodriguez, Katinka Döhner, Stephan Weidinger, Thomas Werfel, Jürgen Harder
BackgroundThe antimicrobial ribonuclease RNase 7 is abundantly expressed in the epidermis of lesional skin of atopic dermatitis (AD). Host RNase inhibitor (RI) binds to RNase 7 and blocks its ribonuclease activity. This study aimed to evaluate the impact of RNase 7–RI interactions on AD.MethodsCultured human primary keratinocytes, with siRNA‐mediated downregulation of RNase 7 and RI, were stimulated
-
Lin−CD117+CD34+FcεRI+ progenitor cells are increased in chronic spontaneous urticaria and predict clinical responsiveness to anti‐IgE therapy Allergy (IF 12.4) Pub Date : 2024-04-18 Katie Ridge, Barry Moran, P. Abigail Alvarado‐Vazquez, Jenny Hallgren, Mark A. Little, Alan D. Irvine, Cliona O'Farrelly, Jean Dunne, Conor M. Finlay, Niall Conlon
BackgroundChronic spontaneous urticaria (CSU) is a common, debilitating skin disorder characterized by recurring episodes of raised, itchy and sometimes painful wheals lasting longer than 6 weeks. CSU is mediated by mast cells which are absent from peripheral blood. However, lineage−CD34hiCD117int/hiFcεRI+ cells in blood have previously been shown to represent a mast cell precursor.MethodsWe enumerated
-
Sunflower seed allergy: Identification of novel 2S‐albumins as potential marker allergens Allergy (IF 12.4) Pub Date : 2024-04-15 J. Achour, M. Reche, T. Valbuena, C. Chapuis, B. Guillon, O. Galet, K. Adel‐Patient, H. Bernard, S. Hazebrouck
-
Long‐term follow‐up of neutrophil activation after severe‐to‐critical SARS‐CoV‐2 infection: A longitudinal study Allergy (IF 12.4) Pub Date : 2024-04-13 Simon Valentin, Veronique Regnault, Jean‐Louis Gueant, Bruno Ribeiro Baptista, Thery Abel, Patrick Lacolley, Frederic Schlemmer, Ari Chaouat, François Chabot, Rosa‐Maria Gueant‐Rodriguez
-
SM17, a new IL‐17RB‐targeting antibody, ameliorates disease progression in a mouse model of atopic dermatitis Allergy (IF 12.4) Pub Date : 2024-04-09 Lik Hang Lam, Weimin Li, Wai Chung Wu, Kai Cheung Chow, Wai Yin Dennis Au, Guolin Xu, Ge Wang, Xuchen Qian, Ka Man Ng, Shaik Abdullah Nawabjan, Muthu Iswarya Gandhi Sethuraman, Wai Yan Choi, Billy Kwok Chong Chow, Shui On Leung, Chin Wai Hui
-
Medical algorithm: Diagnosis and treatment of drug reaction with eosinophilia and systemic symptoms in adult patients Allergy (IF 12.4) Pub Date : 2024-04-08 Marie‐Charlotte Brüggen, Stephan Traidl, Yasutaka Mitamura, Sarah Walsh, Lars E. French, Nicholas Gulati, Elizabeth Phillips, Emanual Maverakis, Saskia Ingen‐Housz‐Oro
CONFLICT OF INTEREST STATEMENT The authors have no conflicts of interest to declare.
-
Preventive allergen immunotherapy with inhalant allergens in children Allergy (IF 12.4) Pub Date : 2024-04-08 Varsha Dwivedi, Sonja Kopanja, Klara Schmidthaler, Justyna Sieber, Christina Bannert, Zsolt Szépfalusi
The efficacy and safety of preventive allergen immunotherapy (pAIT) in children are currently under investigation. Here, we provide an overview of pAIT with respiratory allergens concerning the prevention of new sensitizations, allergic disease onset and progression as well as further immunomodulatory effects. Three databases were searched for clinical pAIT studies in children. Selected publications
-
AM‐301, a barrier‐forming nasal spray, versus saline spray in seasonal allergic rhinitis: A randomized clinical trial Allergy (IF 12.4) Pub Date : 2024-04-06 Sven Becker, Sachin Deshmukh, Ferdinandus De Looze, Veronica Francardo, Jessie Lee, Anthony McGirr, Zachary Nathan, Christopher Rook, Thomas Meyer
-
Prior respiratory syncytial viral infection contributes to severe COVID‐19 illness: A nationwide cohort study Allergy (IF 12.4) Pub Date : 2024-04-05 Hwan Jin Lee, Min Ji Kim, Jong Seung Kim, Yong Chul Lee, Jae Seok Jeong
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to be a major threat to public health around the world.1 Recently, there has been a growing recognition of the influence that prior respiratory viral infections, such as influenza, have on the outcomes of COVID-19.2 However, little is known about the long-term effects of RSV infection
-
Extracellular vesicle miRNAs drive aberrant macrophage responses in NSAID‐exacerbated respiratory disease Allergy (IF 12.4) Pub Date : 2024-04-04 Franziska Hartung, Pascal Haimerl, Sonja Schindela, Veronika Mussack, Benedikt Kirchner, Fiona D. R. Henkel, Ulrike Bernhardt, Ulrich M. Zissler, Rachel Santarella‐Mellwig, Michael Pfaffl, Carsten B. Schmidt‐Weber, Adam M. Chaker, Julia Esser‐von Bieren
-
Patterns of allergen recognition in Ligustrum polysensitized patients: An immunoproteomics approach Allergy (IF 12.4) Pub Date : 2024-04-04 Raúl Porras‐Gutiérrez‐de‐Velasco, Blessy Maruthukunnel‐Mani, Juan Carlos Vizuet‐de‐Rueda, Josaphat Miguel Montero‐Vargas, Luis M. Teran
Members of the Oleaceae family, including Ligustrum (privet), Olea (olive), and Fraxinus (ash), are recognized as important causes of allergenic respiratory diseases worldwide. In Mexico City, nearly 37% of allergic patients have been reported to show sensitization to Ligustrum lucidum pollen, correlating with sensitization to Fraxinus, a very abundant tree in the city.1 Lig v 1, a homolog of Ole e
-
Targeting IL‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years Allergy (IF 12.4) Pub Date : 2024-04-02 Emma Guttman‐Yassky, Kenji Kabashima, Delphine Staumont‐Salle, Walter K. Nahm, Sylvia Pauser, Joel Correa Da Rosa, Britta Cathrina Martel, Daniel Elenius Madsen, Mads Røpke, Petra Arlert, Louise Steffensen, Andrew Blauvelt, Kristian Reich
-
EAACI guidelines on environmental science for allergy and asthma: The impact of short‐term exposure to outdoor air pollutants on asthma‐related outcomes and recommendations for mitigation measures Allergy (IF 12.4) Pub Date : 2024-04-02 Ioana Agache, Isabella Annesi‐Maesano, Lorenzo Cecchi, Benedetta Biagioni, Kian Fan Chung, Bernard Clot, Gennaro D'Amato, Athanasios Damialis, Stefano del Giacco, Javier Dominguez‐Ortega, Carmen Galàn, Stefanie Gilles, Stephen Holgate, Mohamed Jeebhay, Stelios Kazadzis, Kari Nadeau, Nikolaos Papadopoulos, Santiago Quirce, Joaquin Sastre, Fiona Tummon, Claudia Traidl‐Hoffmann, Jolanta Walusiak‐Skorupa
The EAACI Guidelines on the impact of short‐term exposure to outdoor pollutants on asthma‐related outcomes provide recommendations for prevention, patient care and mitigation in a framework supporting rational decisions for healthcare professionals and patients to individualize and improve asthma management and for policymakers and regulators as an evidence‐informed reference to help setting legally
-
Algorithms in allergy: Diagnosis, pathogenesis, and treatment of chronic spontaneous urticaria Allergy (IF 12.4) Pub Date : 2024-04-01 Allen P. Kaplan, Marta Ferrer
CONFLICT OF INTEREST STATEMENT Marta Ferrer has received honoraria (advisory board, speaker) from Novartis, Menarini, Uriach, FAES, Pfizer and MSD and has received a research Grant from GSK and Novartis.
-
-
IgE‐mediated allergic diseases are associated with Alzheimer's disease Allergy (IF 12.4) Pub Date : 2024-03-30 Andrzej Bozek, Magdalena Krupka‐Olek, Aleksandra Kawczyk Krupka
-
Patients' values and preferences for health states in allergic rhinitis—An artificial intelligence supported systematic review Allergy (IF 12.4) Pub Date : 2024-03-29 Jan Brozek, Ewa Borowiack, Ewelina Sadowska, Artur Nowak, Bernardo Sousa‐Pinto, Rafael José Vieira, Antonio Bognanni, Juan Jose Yepes Nuñez, Yuan Zhang, Torsten Zuberbier, Jean Bousquet, Holger J. Schünemann
BackgroundAllergic rhinitis (AR) impacts patients' physical and emotional well‐being. Assessing patients' values and preferences (V&P) related to AR is an essential part of patient‐centered care and of the guideline development process. We aimed to systematically summarize the information about patients' V&P on AR and its symptoms and impact on daily life.MethodsWe conducted systematic review in a
-
Environmental exposures drive the development of allergic diseases Allergy (IF 12.4) Pub Date : 2024-03-27 Luo Zhang, Cezmi A. Akdis
The global prevalence of allergic diseases, such as allergic rhinitis (AR) and asthma, has gradually increased since 1960s. AR prevalence has surged by 5%–25% across various regions in the past few decades.1 Similarly, the prevalence of asthma has progressively increased over the last 65 years in industrialized countries and 30–40 years in urbanized areas of low- and middle-level income countries,
-
Interleukin 31 transcription in a canine model of acute atopic dermatitis does not correlate with T‐cell infiltration Allergy (IF 12.4) Pub Date : 2024-03-27 Nicky Craig, Kim Ahrens, Rachel Wilkes, Tanja Opriessnig, Deborah V. Hoyle, Barry Bradford, Scott Maxwell, Jorge del Pozo, Maciej Parys, Takanori Kitamura, Rosanna Marsella
-
Mast cell activation identified through urine mediators Allergy (IF 12.4) Pub Date : 2024-03-27 Matthew P. Giannetti, Grace Godwin, Julia Middlesworth, Andrew Espeland, Jennifer Nicoloro‐SantaBarbara, Mariana Castells
-
Response to Correspondence to “Short‐course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy” Allergy (IF 12.4) Pub Date : 2024-03-25 P. J. de Kam, S. Zielen, J. A. Bernstein, U. Berger, M. Berger, M. Cuevas, D. Cypcar, A. Fuhr‐Horst, W. A. Greisner, M. Jandl, S. Laßmann, M. Worm, J. Matz, E. Sher, C. Smith, G. C. Steven, R. Mösges, M. H. Shamji, L. DuBuske, F. Borghese, K. Oluwayi, T. Zwingers, M. Seybold, O. Armfield, M. D. Heath, S. J. Hewings, M. F. Kramer, M. A. Skinner
-
Chicken meat allergy in children: Complex sensitization profiles with newly described allergen candidates Allergy (IF 12.4) Pub Date : 2024-03-25 T. Guiddir, H. Sénéchal, M. A. Selva, R. Couderc, I. Swoboda, C. Hilger, A. Kuehn, Y. Chantran, S. Yen‐Nicolaÿ, T. Vrai, G. Ruellou, B. Baudin, P. Poncet, A. Nemni
Chicken meat allergy (ChMA) has an estimated incidence of 0.6%–5%.1 Symptoms range from mild oral syndrome to systemic reactions. Individual sensitization profiles remain poorly understood. The objective was to exhaustively and individually explore the clinical parameters (Table 1) and the IgE repertoire of five children (P1 to P5, 6–12 years old) with primary ChMA, without egg allergy, in order to
-
Lupin, a potential “hidden” food anaphylaxis allergen: An alert from the Allergy‐Vigilance Network® Allergy (IF 12.4) Pub Date : 2024-03-22 Guillaume Pouessel, Dominique Sabouraud‐Leclerc, Pascale Beaumont, Amandine Divaret‐Chauveau, Eléna Bradatan, Pascale Dumond, Yasemin Karaca, Jean‐Marie Renaudin, Carine Metz‐Favre, Delphine Delalande, Anne‐Karine Correard, Sélina Tscheiller, Xavier Van der Brempt
Lupin is a legume considered as an emerging food allergen, but the true prevalence of lupin allergy is not known.1 Due to the increasing consumption of lupin and its potential cross-reactivity with peanut, the Allergy-Vigilance Network® (AVN) aimed to report lupin-induced anaphylaxis cases and compare their main characteristics to other foods (See Data S1 for Material and Methods). Of the 2708 cases
-
Nasal allergen‐neutralizing antibodies correlate closely with tolerated intranasal allergen challenge dose following grass pollen subcutaneous immunotherapy in patients with local allergic rhinitis Allergy (IF 12.4) Pub Date : 2024-03-14 Ibon Eguiluz‐Gracia, Rebecca V. Parkin, Janice A. Layhadi, Elizabeth Palmer, Xun Meng, Rongfei Zhu, Umit Sahiner, Stephen R. Durham, Maria Jose Torres, Cristobalina Mayorga, Carmen Rondon, Mohamed H. Shamji
-
High burden of clonal mast cell disorders and hereditary α‐tryptasemia in patients who need Hymenoptera venom immunotherapy Allergy (IF 12.4) Pub Date : 2024-03-13 Peter Korošec, Gunter J. Sturm, Jonathan J. Lyons, Tinkara Pirc Marolt, Manca Svetina, Mitja Košnik, Mihaela Zidarn, Mark Kačar, Nina Frelih, Nika Lalek, Ajda Demšar Luzar, Samo Zver, Matevž Škerget, Ewa Czarnobilska, Wojciech Dyga, Sanja Popović Grle, Miroslav Samarzija, Lisa Arzt‐Gradwohl, Urban Čerpes, Grzegorz Porebski, Branko Pevec, Eva Schadelbauer, Peter Kopač, Julij Šelb, Matija Rijavec
-
RNA‐sequencing of paired tape‐strips and skin biopsies in atopic dermatitis reveals key differences Allergy (IF 12.4) Pub Date : 2024-03-13 Blaine Fritz, Anne‐Sofie Halling, Isabel Díaz‐Pinés Cort, Maria Oberländer Christensen, Amalie Thorsti Møller Rønnstad, Caroline Meyer Olesen, Mette Hjorslev Knudgaard, Claus Zachariae, Steffen Heegaard, Jacob P. Thyssen, Thomas Bjarnsholt
-
Correction to Long‐term immune response accompanies clinical outcomes in severe asthmatics treated with anti‐IL‐5/IL‐5R biologics Allergy (IF 12.4) Pub Date : 2024-03-12
Citation: Lorente-Sorolla C, Bernaola J, Sánchez-Mellado D, Gil-Martínez M, Naharro-González S, Betancor D, Fernández-Nieto M, Pinillos-Robles EJ, Santillán Coello JM, Villacampa-Aubá JM, Rodríguez-Nieto MJ, Sastre J, Valverde-Monge M, Rodrigo-Muñoz JM, Del Pozo V. Long-term immune response accompanies clinical outcomes in severe asthmatics treated with anti-IL-5/IL-5R biologics. Allergy. 2023 Nov;78(11):3027-3031
-
Disparities in pediatric anaphylaxis triggers and management across Asia Allergy (IF 12.4) Pub Date : 2024-03-10 Agnes Sze Yin Leung, Elizabeth Huiwen Tham, Punchama Pacharn, Yuhan Xing, Hoang Kim Tu Trinh, Sooyoung Lee, Kangmo Ahn, Pantipa Chatchatee, Sakura Sato, Motohiro Ebisawa, Bee Wah Lee, Gary Wing Kin Wong
-
Reply to the correspondence on “Basophil activation test as predictor of severity and threshold of allergic reactions to egg” Allergy (IF 12.4) Pub Date : 2024-03-11 Alexandra F. Santos, Grammatiki Antoneria, Zainab Jama, Jana Ilangovan, Vikki Houghton
-
Prodromal symptoms of hereditary angioedema (HAE) attacks: A patient survey in UK and Spain Allergy (IF 12.4) Pub Date : 2024-03-11 Patrick F. K. Yong, Mar Guilarte
-
Neonatal skin dysbiosis to infantile atopic dermatitis: Mitigating effects of skin care Allergy (IF 12.4) Pub Date : 2024-03-09 Reika Aoyama, Seitaro Nakagawa, Yoko Ichikawa, Naohiro Inohara, Yuriko Yamazaki, Tomoka Ito, Takashi Sugihira, Michihiro Kono, Masashi Akiyama, Hiroki Takahashi, Akiko Takaya, Fumitaka Ichikawa, Taiji Nakano, Seiko Tanaka, Yutaka Koyano, Manabu Fujimoto, Gabriel Núñez, Naoki Shimojo, Yuumi Nakamura
Patients with atopic dermatitis (AD) harbor Staphylococcus aureus in lesional skin, causing dysbiosis, linked to disease flares and progression.1 The onset of dysbiosis-related AD during infancy remains unclear. To clarify this, we performed a longitudinal microbiome analysis in an interventional cohort study. In total, 177 infants, all of whom received skin care, were included in this study (Figure S1A
-
Legends of allergy and immunology: Kenji Izuhara Allergy (IF 12.4) Pub Date : 2024-03-08 Satoshi Nunomura, Kazunari Sugita, Kazuhiko Arima
CONFLICT OF INTEREST STATEMENT Satoshi Nunomura and Kazunari Sugita have no conflicts to declare, while Kazuhiko Arima is a full-time employee and stockholder of Sanofi K.K.
-
Type 1/17 CD103+CD4+ nasal‐resident memory T cells in non‐eosinophilic chronic rhinosinusitis with nasal polyps Allergy (IF 12.4) Pub Date : 2024-03-06 Min‐Seok Rha, Gyeongyeob Kim, Sol Lee, Chan Min Jung, Young‐Woo Lee, Hae Eun Noh, Yeonsu Jeong, Hyung‐Ju Cho, Chang‐Hoon Kim